Names | |
---|---|
IUPAC name
Gallium trinitrate
| |
Other names
Gallium(III) nitrate
Nitric acid, gallium salt | |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
DrugBank | |
ECHA InfoCard | 100.033.453 |
EC Number |
|
PubChem CID
|
|
UNII | |
UN number | 1477 |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
Ga(NO3)3 | |
Molar mass | 255.7377 g/mol |
Hazards | |
GHS labelling: | |
Danger | |
H272, H314, H315, H319, H335 | |
P210, P220, P221, P260, P261, P264, P271, P280, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P337+P313, P362, P363, P370+P378, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Gallium nitrate (brand name Ganite) is the gallium salt of nitric acid with the chemical formula Ga(NO3)3. It is a drug used to treat symptomatic hypercalcemia secondary to cancer. It works by preventing the breakdown of bone through the inhibition of osteoclast activity, thus lowering the amount of free calcium in the blood.[1][2] Gallium nitrate is also used to synthesize other gallium compounds.